<!-- ----------------------------------------------------------------- -->
# Chapter 6/Paper 4 {background-color="#fff0a2"}
Improving the spatial and temporal resolution of burden of disease measures with Bayesian models
![](imgs/pillars_p4.png){width=80%}

<!-- ----------------------------------------------------------------- -->
## Under review at *Spatial and Spatio-temporal Epidemiology*
<br>
**James Hogg**, K. Staples, A. Davis, S. Cramb, C. Patterson, L. Kirkland, M. Gourley, J. Xiao, W. Sun. Improving the spatial and temporal resolution of burden of disease measures with Bayesian models.
<br>
<br>
<div class="small-text">**Status**: <span class="blB">Second round</span> of revisions</div

<!-- ----------------------------------------------------------------- -->
## Background {.smaller}

### Burden of disease (BOD)

::::: {.columns}

:::: {.column width="68%"}

::: {.incremental}
- BOD estimates $\to$ identify diseases causing excess burden [@Murray1997; @GBD2016;@Schmidt2020; @RN121; @Steel2018]
- Disability-adjusted life years (<span class="blB">DALY</span>)
  - Linear and non-linear combinations of <span class="blB">fatal</span> (e.g., mortality) and <span class="blB">non-fatal</span> (e.g., prevalence) burden
  - Fatal component $=$ ‚Äòyears of life lost‚Äô (<span class="blB">YLL</span>)
  - Non-fatal component $=$ ‚Äòyears lived with disability‚Äô (<span class="blB">YLD</span>)
:::
::::

:::: {.column width="28%"}
![](imgs/chp6/bod.webp){width=100% .soft-edges}

::::

:::::

<!-- ----------------------------------------------------------------- -->
## {.smaller}

### Full BOD studies

::: {.incremental}
- Aim to calculate DALYs for <span class="blB">all</span> causes (typically over 200)
- Prioritise healthcare resources by <span class="blB">ranking diseases</span>
![](imgs/chp6/gbd.png){width=100% .soft-edges}
:::

### Bayesian modelling

::: {.incremental}
- <span class="blB">Countless</span> studies use Bayesian models in **disease mapping**
- <span class="blR">Few</span>       studies use Bayesian models in **BOD studies** [@Steel2018; @GBD2015; @CODEm; @RN652; @RN653]
:::

::: {.notes}
not fully Bayesian, fail to acknowledge relevant applied literature or enforce strict data requirements
Too complex (i.e., not practical)
:::

<!-- ----------------------------------------------------------------- -->
## {auto-animate=true}

::: {style="margin-top: 100px;"}
**No** BOD studies
:::

<!-- ----------------------------------------------------------------- -->
## {.smaller auto-animate=true}

::: {style="margin-top: 200px; font-size: 3em; color: red;"}
**No** BOD studies 
:::

::: {.incremental}
- Use SAE models for survey microdata
- Consider models applicable to the full scope of data in full BOD studies
- **Australia**
	- <span class="blR">Use</span> fully Bayesian models
	- <span class="blR">No</span> small area estimates
:::

<!-- ----------------------------------------------------------------- -->
## {.center}

::: {.quote-box}
**Contribution** üéâ

A principled and practical set of Bayesian spatiotemporal methods for modelling the wide range of mortality and prevalence data necessary for full BOD studies.
:::

<!-- ----------------------------------------------------------------- -->
## {.center background-color="#fff0a2"}

::: {.center style="font-size: 0.7em"}
*Thesis aim*
:::

::: {.center style="font-size: 1.5em"}
Develop and apply Bayesian small area methods to health data in Australia
:::

<br>
<br>

::: {.center style="font-size: 0.7em"}
üëâ **Sparsity issues**

üëâ **Improve spatial resolution**

üëâ **Support informed decision making**
:::

<!-- ----------------------------------------------------------------- -->
## ‚õî Tangent Alert ‚õî {.smaller}

- Full BOD studies $\to$ conducted by **government agencies** in Australia
- Models are **intentionally** simple $\to$ <span class="blB">accessible</span> and <span class="blB">practical</span> 
	- Ensure applicability of models to future full BOD studies
- **Novelty**
	- Not in the <span class="blR">development</span> of new Bayesian models
	- <span class="blB">Application</span> of existing models to the field of BOD

<!-- ----------------------------------------------------------------- -->
## Methods {.smaller}

<span class="blB">Standard age-year-time (SAYT) model</span> 

::::: {.columns}

:::: {.column width="28%"}
![](imgs/chp6/disease.webp){width=100% .soft-edges}

::::

:::: {.column width="68%"}

::: {.incremental}
- Input data: 
	- **Aggregated counts** by area, year, age, and sex
- Output data: 
	- **Smoothed counts** for each area, year, age, and sex
- Model details:
	- **Poisson model**
	- Population as offset
	- Spatial, temporal and space-time **random effects**
- Applicable to:
	- **Mortality** or **prevalence** counts
:::
::::

:::::

<!-- ----------------------------------------------------------------- -->
## Methods {.smaller}

<span class="blB">Weighted multilevel regression and poststratification (MrP)</span>
<br>
**First use** of small area estimation in BOD

::::: {.columns}

:::: {.column width="28%"}

![](imgs/chp6/mrp.webp){width=100% .soft-edges}
::::

:::: {.column width="68%"}

::: {.incremental}
- Input data: 
	- **Individual level data**
- Output data: 
	- **Probabilities** for all combinations of area, year, age, and sex
- Model details:
	- **Logistic model** with poststratification step [@Park2004]
	- Likelihood is weighted using **pseudo-likelihood** [@Savitsky2016]
	- Spatial and temporal **random effects**
- Applicable to:
	- **Survey microdata**
:::
::::

:::::

<!-- ----------------------------------------------------------------- -->
## Case study {.smaller}

::: {.incremental}
- Data was supplied by Department of Health Western Australia (<span class="blB">DOHWA</span>)
- Two conditions: <span class="blB">Asthma</span> and coronary heart disease (<span class="blB">CHD</span>)
- Geographic: <span class="blB">Local Government Areas</span> (n = 137) in Western Australia
- Time: <span class="blB">2015 to 2020</span> inclusive
- Used <span class="blB">fully Bayesian methods</span> with $\texttt{nimble}$
:::

### Objective

::: {.incremental}
1. Produce <span class="blB">modelled estimates</span> of:
	i) Mortality and age-standardised YLLs (ASYLLs)
	ii) Prevalence/proportions and ASYLDs
2. <span class="blB">Compare</span> to raw results (i.e., no modelling)
:::

<!-- ----------------------------------------------------------------- -->
## {.center}

![Comparison of the distribution of the point estimates from the Bayesian models and basic stratification (i.e., raw).](imgs/chp6/compraw_ALL.jpeg){.r-stretch}

<!-- ----------------------------------------------------------------- -->
## {.center}

![Comparison of the 822 annual LGA point estimates and their reliability (% of RSEs less than 50%) for modeled and raw BOD measures by condition.](imgs/chp6/results.png){.r-stretch}

<!-- ----------------------------------------------------------------- -->
## {.center .smaller background-color="#ffffff"}

:::: {.finding-box}
**Key findings** üì¢

::: {.incremental}
- <span class="blB">Bayesian models</span> $\to$ increased the *reliability, certainty and reportability* of estimates
<!-- - Demonstrated **feasibility** of incorporating spatio-temporal models into <span class="blB">full BOD studies</span>
  - Provide **ranks** for disease burden from **all** causes by **small areas** -->
- Bayesian vs. raw: 
	- <span class="blB">Agreed</span> (mostly!)
  - Discrepancies due to <span class="blB">age-standardisation</span> OR <span class="blB">paradigm differences</span>
:::

::::

<!-- ----------------------------------------------------------------- -->
## Objective 3 {.smaller}

<span class="blB">Burden of disease</span>

‚ùï **3.1 Method:** Explore and develop appropriate Bayesian spatiotemporal methods to model the wide range of health data used in full BOD studies.

‚ùï **3.2 Application:** Using two very different diseases ^[Coronary heart disease (CHD) and asthma in Western Australia], generate and map the first small area level BOD estimates in Australia.

<!-- ----------------------------------------------------------------- -->
## Objective 3 {.smaller}

<span class="blB">Burden of disease</span>

‚úÖ **3.1 Method:** 

‚úÖ **3.2 Application:**

<!-- ----------------------------------------------------------------- 
## Discussion {.scrollable .smaller}

### Limitations 

::: {.incremental}

- Relative simplicity of models
- Validation
:::

### Future work

::: {.incremental}

- Computation time
  - Explore faster alternatives to Bayesian inference such as integrated nested Laplace approximation (INLA) [@Rue2009] or variational inference [@fox_2012].
- Model complexity
  - Deeper interactions
  - More individual level covariates

:::-->